Skip to content
Login
Search:
CROI Conference
CROI ConferenceCROI Conference
  • About CROI
    • CROI 2027 Important Dates
    • CROI Foundation
    • Scientific Program Committee and Community Liaison Subcommittee
    • Funding and Grant Support
    • IAS-USA
    • Policies, Website, and Copyrights
    • Illustrations of HIV, HCV, and SARS-CoV-2 Viruses
    • Contact Us
  • Abstracts
    • CROI Abstract Categories
    • Abstract Guidelines and Submission
    • Assignment of Abstract Copyright to CROI
    • People-First Language and the Use of Appropriate Terminology
  • Presenters
    • Invited Presenters and Moderators
    • Letter Of Invitation (For Visa And Other Purposes)
  • Attendees
    • Who Can Attend
    • Letter Of Invitation (For Visa And Other Purposes)
    • Affiliated and Proximate Activities
    • Frequently Asked Questions
  • Scholarships
    • New Researcher Scholarship
    • International Researcher Scholarship
    • Community Educator and Mentor Scholarships
  • Program
    • CROI 2027 Program
    • Our Voices
    • Media
    • Embargo Policies And Press Release Policies
    • Resources From Prior Years
    • Webcasts
    • Abstracts and ePoster Archive
    • CROI Issues of TAM
  • About CROI
    • CROI 2026 Preliminary Important Dates and Deadlines
    • CROI Foundation
    • Scientific Program Committee and Community Liaison Subcommittee
    • Funding and Grant Support
    • IAS-USA
    • Policies, Website, and Copyrights
    • Illustrations of HIV, HCV, and SARS-CoV-2 Viruses
    • Contact Us
  • Abstracts
    • Abstract Guidelines and Submission
    • CROI Abstract Categories
    • Assignment of Abstract Copyright to CROI
    • People-First Language and the Use of Appropriate Terminology
  • Presenters
    • Invited Presenters and Moderators
    • Oral Abstract Presentation Guidelines
    • Poster Presentation Guidelines
    • Themed Discussion Guidelines
    • Plain Language Summaries: A Mile-High View at CROI 2026
    • People-First Language and the Use of Appropriate Terminology
    • Letter Of Invitation (For Visa And Other Purposes)
  • Attendees
    • Registration
    • Who Can Attend
    • Media Accreditation and Registration
    • Affiliated and Proximate Activities
    • Frequently Asked Questions
  • Scholarships
    • New Researcher Scholarship
    • International Researcher Scholarship
    • Community Educator and Mentor Scholarships
    • Scholarship Travel
  • Program
    • CROI 2027 Program
    • CROI 2026 Resources
    • Our Voices
    • Media
    • Resources From Prior Years
    • Webcasts
    • Abstracts and ePoster Archive
    • CROI Issues of TAM
  • CROI 2027 Important Dates

Search Results for: node/PEP: Remember Me?

Specificity of V3-specific Neutralizing Responses in HIV-1 Infected Women

By Enthusiast Inc MDFebruary 27, 2015

…decreased in the presence of SF162 V3 as compared to the scrambled peptide and no peptide (median ID50 671, 1399, 2930, for SF162 V3 peptide, scrambled peptide, and no peptide,…

293 – Identification of the First HIV-1 p24 Peptide for the Amerindian HLA-B*39:02 Allele

By Jimmy He PharmD, DScApril 1, 2026

…responses. Furthermore, competitive peptide assays revealed that polymorphisms selected by HLA-B39:02 alter peptide binding affinity to the HLA molecule. Methods We recruited a cohort of 14 men living with HIV…

CTL EPITOPES FROM STRUCTURALLY IMPORTANT HIV PROTEINS ARE IDENTIFIED IN REBOUND HIV

By Jimmy He PharmD, DScMarch 3, 2023

…CTL epitopes within structurally important HIV protein regions that avoid CTL immune escape mutations. Methods: Employing the IMAP, we generated 8-14 mer overlapping peptides containing amino acid residues that are…

Reaching ECP Users With HIV and PEP Services in Kenyan Pharmacies

By Jimmy He PharmD, DScMarch 6, 2024

…convenient outreach points for HIV prevention services including PEP. We assessed the willingness of AGYW seeking ECP to test for HIV and initiate PEP Methods: We assessed willingness to test…

1277 – Characteristics of Breakthrough Chlamydia Cases Among Cisgender Women Assigned to Doxycycline PEP

By Jimmy He PharmD, DScApril 18, 2025

…of doxycycline PEP in that trial was low. Methods We describe 35 breakthrough cases of incident Chlamydia trachomatis among 32 participants assigned to doxycycline PEP (n=224) within an open-label randomized…

1279 – Factors Influencing Doxy-PEP Awareness Among Sexual/Gender Minorities: A Web-Based Survey in Brazil

By Jimmy He PharmD, DScMarch 20, 2025

…doxy-PEP among SGM in Brazil. Methods A cross-sectional online survey was conducted among adults (18+ years) living in Brazil, recruited via advertisements on dating apps (Scruff and Grindr) and social…

1039 – Balancing STI Prevention and Antibiotic Use: Simulated Doxy-PEP Strategies in ImPrEP Study

By Jimmy He PharmD, DScMarch 31, 2026

Background Doxy-PEP is an effective strategy for STI prevention, with absent data from Latin America. ImPrEP (2018–2021) evaluated same-day oral PrEP delivery for MSM and TGW in Brazil, Mexico, and…

1042 – Doxy-PEP Associated With Clearance of Mycoplasma genitalium Urogenital Infection

By Jimmy He PharmD, DScMarch 31, 2026

…a convenience sample of DoxyPEP trial participants (ppts). Men who have sex with men (MSM) and transgender women (TGW) with HIV or on PrEP were randomized 2:1 to doxy-PEP or…

1044 – Doxy-PEP Knowledge, Attitudes, and Practices Among HIV and PrEP Providers: A Pilot Study

By Jimmy He PharmD, DScMarch 31, 2026

Background Doxycycline post-exposure prophylaxis (doxy-PEP) effectively prevents bacterial STIs among men who have sex with men (MSM) and transgender women (TGW). The real-world impact of doxy-PEP will depend partly on…

BIC/FTC/TAF as HIV PEP Was Well-Tolerated With High Adherence and No Seroconversions

By Jimmy He PharmD, DScMarch 6, 2024

…had previously used PEP. Most (86%) were men who have sex with men. Medication adherence was high; among 101 participants with available data, all took all 28 days of PEP…

←1
23
…45678…
910111213141516171819202122232425262728293031323334353637383940414243444546474849505152535455565758596061626364656667686970717273747576777879808182
83→
Copyright © 2026 CROI Foundation/IAS-USA. All Rights Reserved.
Website by Enthusiast, Inc.
  • About CROI
  • Presenters
  • Abstracts
  • Scholarships
  • Program
Footer Menu
Go to Top